“The Not-So-Standard Model: Reconsidering Agency-Head Review of Administrative Adjudication Decisions”
Nina A. Mendelson Rebecca S. Eisenberg- Administrative Law
Administrative Law Review
2023
“New Innovation Models in Medical AI”
Nicholson Price Rebecca S. Eisenberg- Law and Technology
- Health Law
Washington University Law Review
2022
“Limiting Agency Head Review in the Design of Administrative Adjudication”
Nina A. Mendelson Rebecca S. Eisenberg- Administrative Law
Yale Journal of Regulation: Notice and Comment
2022
“Anticommons, Transaction Costs, and Patent Aggregators”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Research Handbook on the Economics of Intellectual Property Law
2019
“Opting Into Device Regulation in the Face of Uncertain Patentability”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
- Law and Technology
Marquette Intellectual Property Law Review
2019
“Cannabis for Medical Use: FDA and DEA Regulation in the Hall of Mirrors”
Rebecca S. Eisenberg- Health Law
Food and Drug Law Journal
2019
“A Functional Approach to Judicial Review of PTAB Rulings on Mixed Questions of Law and Fact”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Iowa Law Review
2019
“Shifting Institutional Roles in Biomedical Innovation in a Learning Healthcare System”
Rebecca S. Eisenberg- Law and Technology
- Health Law
Journal of International Economics
2018
“Universities: The Fallen Angels of Bayh-Dole?”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Daedalus
2018
“Intellectual Property and Public Health”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
- Health Law
Oxford Handbook of Intellectual Property Law
2017
Science
2017
“Patent Punting: How FDA and Antitrust Courts Undermine the Hatch-Waxman Act to Avoid Dealing with Patents”
Rebecca S. Eisenberg Daniel A. Crane- Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2015
“Diagnostics Need Not Apply”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
- Law and Technology
Boston University Journal of Science & Technology Law
2015
“Patents and Regulatory Exclusivity in the USA”
Rebecca S. Eisenberg
Encyclopedia of Health Economics
2014
“Prometheus Rebound: Diagnostics, Nature, and Mathematical Algorithms”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Yale Law Journal Online
2013
“Wisdom of the Ages or Dead-Hand Control? Patentable Subject Matter for Diagnostic Methods After In Re Bilski”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Case Western Reserve Journal of Law, Technology & the Internet
2012
“Patents and Regulatory Exclusivity”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
The Oxford Handbook of the Economics of the Biopharmaceutical Industry
2012
“Data Secrecy in the Age of Regulatory Exclusivity”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
The Law and Theory of Trade Secrecy: A Handbook of Contemporary Research
2011
“Patent Costs and Unlicensed Use of Patented Inventions”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
University of Chicago Law Review
2011
“Costs, Norms, and Inertia: Avoiding an Anticommons for Proprietary Research Tools”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Working Within the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society
2010
Science
2009
“Patents and the Progress of Science: Exclusive Rights and Experimental Use”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
The Economics of Innovation Policy
2008
“Noncompliance, Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Houston Law Review
2008
“Pharma’s Nonobvious Problem”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Lewis and Clark Law Review
2008
“The Role of the FDA in Innovation Policy”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2007
“The Supreme Court and the Federal Circuit: Visitation and Custody of Patent Law”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Michigan Law Review First Impressions
2007
“The Story of Diamond v. Chakrabarty: Technological Change and the Subject Matter Boundaries of the Patent System”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Intellectual Property Stories
2006
“Patents and Data-Sharing in Public Science”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Industrial and Corporate Change
2006
“Harnessing and Sharing the Benefits of State-Sponsored Research: Intellectual Property Rights and Data Sharing in California’s Stem Cell Initiative”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Berkeley Technology Law Journal
2006
“BioTech. Patents: Looking Backward While Moving Forward”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Nature Biotechnology
2006
“How Can You Patent Genes?”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Genetics: Science, Ethics and Public Policy: A Reader
2005
“Learning the Value of Drugs - Is Rofecoxib a Regulatory Success Story?”
Rebecca S. Eisenberg- Health Law
New England Journal of Medicine
2005
Yale Journal of Health Policy, Law, and Ethics
2005
“Obvious to Whom? Evaluating Inventions from the Perspective of PHOSITA”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Berkeley Technology Law Journal
2004
Handbook of Stem Cells
2004
“Reexamining Drug Regulation from the Perspective of Innovation Policy”
Rebecca S. Eisenberg- Health Law
Journal of Institutional and Theoretical Economics
2004
“Patents, Product Exclusivity, and Information Dissemination: How Law Directs Biopharmaceutical Research and Development”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Fordham Law Review
2003
“Patenting Genome Research Tools and the Law”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Comptes rendus Biologies
2003
Science
2003
“Reaching Through the Genome”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Perspectives on Properties of the Human Genome Project
2003
“Can Patents Deter Innovation? The Anticommons in Biomedical Research”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Rights and Resources
2003
“Bayh-Dole Reform and the Progress of Biomedicine”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Law and Contemporary Problems
2003
“Bayh-Dole Reform and the Progress of Biomedicine”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
American Scientist
2003
“The Role of Patents in Exploiting the Genome”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
The Genomic Revolution: Unveiling the Unity of Life
2002
“Why the Gene Patenting Controversy Persists”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002
“Public vs. Proprietary Science: A Fruitful Tension?”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
Daedalus
2002
“Patents on DNA Sequences: Molecules and Information”
Rebecca S. Eisenberg- Intellectual Property and Antitrust
The Commodification of Information
2002